Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice
Guangjin Zhou, … , Daniel I. Simon, Mukesh K. Jain
Guangjin Zhou, … , Daniel I. Simon, Mukesh K. Jain
Published November 19, 2012
Citation Information: J Clin Invest. 2012;122(12):4727-4731. https://doi.org/10.1172/JCI66056.
View: Text | PDF
Brief Report Cardiology Article has an altmetric score of 13

Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice

  • Text
  • PDF
Abstract

The endothelium regulates vascular homeostasis, and endothelial dysfunction is a proximate event in the pathogenesis of atherothrombosis. Stimulation of the endothelium with proinflammatory cytokines or exposure to hemodynamic-induced disturbed flow leads to a proadhesive and prothrombotic phenotype that promotes atherothrombosis. In contrast, exposure to arterial laminar flow induces a gene program that confers a largely antiadhesive, antithrombotic effect. The molecular basis for this differential effect on endothelial function remains poorly understood. While recent insights implicate Kruppel-like factors (KLFs) as important regulators of vascular homeostasis, the in vivo role of these factors in endothelial biology remains unproven. Here, we show that endothelial KLF4 is an essential determinant of atherogenesis and thrombosis. Using in vivo EC-specific KLF4 overexpression and knockdown murine models, we found that KLF4 induced an antiadhesive, antithrombotic state. Mechanistically, we demonstrated that KLF4 differentially regulated pertinent endothelial targets via competition for the coactivator p300. These observations provide cogent evidence implicating endothelial KLFs as essential in vivo regulators of vascular function in the adult animal.

Authors

Guangjin Zhou, Anne Hamik, Lalitha Nayak, Hongmei Tian, Hong Shi, Yuan Lu, Nikunj Sharma, Xudong Liao, Andrew Hale, Lauren Boerboom, Ryan E. Feaver, Huiyun Gao, Amar Desai, Alvin Schmaier, Stanton L. Gerson, Yunmei Wang, G. Brandon Atkins, Brett R. Blackman, Daniel I. Simon, Mukesh K. Jain

×

Figure 3

KLF4 regulates endothelial gene expression.

Options: View larger image (or click on image) Download as PowerPoint
KLF4 regulates endothelial gene expression.
(A) KLF4 expression was upre...
(A) KLF4 expression was upregulated by an atheroprotective hemodynamic shear stress profile (versus atheroprone). (B and C) Adenoviral overexpression of KLF4 maintained an atheroprotective gene program in HUVECs exposed to (B) atheroprone flow and (C) cytokine (n = 6 experiments). EV, empty virus; AdK4, KLF4-expressing adenovirus. (D) siRNA-mediated KLF4 knockdown led to a proatherogenic gene program even in the presence of atheroprotective flow (n = 8 experiments). siK4, KLF4 siRNA; NS, nonspecific siRNA. (E) KLF4 binding to p300 was mediated via the P3ID. Immunoprecipitation experiments were performed 3 times in 293 cells. A representative experiment is shown. (F) KLF4 worked synergistically with p300 in activation of the TM promoter. COS-7 cells were transfected with vector plasmid, expression plasmids, and a TM promoter reporter plasmid. Reporter activity is expressed as relative luciferase units (RLU). (G) Inhibition by KLF4 of p65-mediated VCAM1 promoter activity required the KLF4 P3ID (n = 3 experiments; 6 replicates per experiment). *P ≤ 0.05; **P ≤ 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 1 X users
115 readers on Mendeley
See more details